Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib

被引：0

作者：

Charles-Schoeman, Christina ^{[1
]}

Valdez, Hernan ^{[2
]}

Soma, Koshika ^{[2
]}

Hwang, Lie-Ju ^{[2
]}

DeMasi, Ryan ^{[2
]}

Boy, Mary ^{[3
]}

McInnes, Iain B. ^{[4
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA USA

[2] Pfizer Inc, New York, NY USA

[3] Pfizer Inc, Groton, CT 06340 USA

[4] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3024

引用

页数：5

共 50 条

[31] Factors Associated With Major Adverse Cardiovascular Events in Patients Treated by Provisional Stenting for Coronary Artery Bifurcation Lesions
Jomaa, Walid
Lassoued, Taha
Chamtouri, Ikram
Ben Hamda, Khaldoun
Maatouk, Faouzi
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (16) : S19 - S19
[32] Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study
Noumegni, Steve Raoul
Didier, Romain
Mansourati, Vincent
Le Moigne, Emmanuelle
Le Mao, Raphael
Hoffmann, Clement
Moreuil, Claire De
Tromeur, Cecile
Le Roux, Pierre-Yves
Nasr, Bahaa
Gentric, Jean-Christophe
Guegan, Marie
Poulhazan, Elise
Lacut, Karine
Bressollette, Luc
Couturaud, Francis
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (04): : 465 - 480
[33] Impact of Phenoconversion on Risk for Major Adverse Cardiovascular Events in Clopidogrel-Treated Post-PCI Patients
Rivera, Jean Malave
Franchi, Francesco
Ortega-Paz, Luis
Doan, Thi
Lopez, Andres
Thomas, Cameron D.
Angiolillo, Dominick J.
Lee, Craig R.
Cavallari, Larisa H.
PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 16 - 16
[34] Accelerated development of cardiovascular risk factors mediates risk for major adverse cardiovascular events in posttraumatic stress disorder
Khalil, Maria
Sinnott, Sinead M.
Civieri, Giovanni
Abohashem, Shady
Grewal, Simran S.
Hanlon, Erin
Assefa, Alula
Qamar, Iqra
Lau, Hui Chong
Karam, Krystel Abi
Aldosoky, Wesam
Shin, Lisa M.
Tawakol, Ahmed
Seligowski, Antonia V.
Osborne, Michael T.
BRAIN BEHAVIOR AND IMMUNITY, 2025, 125 : 148 - 157
[35] RISK FACTORS FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH CANCER TREATED WITH PONATINIB
Pei, Dorothy
Ulhaq, Owais
Go, Rafael
Ali, Abdelrahman
Khalaf, Shaden
Hamzeh, Ihab
Koutroumpakis, Efstratios
Iliescu, Cezar
Deswal, Anita
Palaskas, Nicolas L.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2204 - 2204
[36] Risk factors for cardiovascular events in patients treated with immunotherapy.
Garitaonaindia, Yago
Blanco, Mariola
Franco, Fernando
Torrente, Maria
Calvo, Virginia
Collazo, Ana
Del Alba, Aranzazu Gonzalez
Cristobal Sanchez, Juan
Gutierrez, Lourdes
Royuela, Ana
Nunez Garcia, Beatriz
Mendez, Miriam
Hernandez, Roberto
Cantos Sanchez De Ibarguen, Blanca
Martinez Cutillas, Marta
Traseira, Cristina
Aguado, Ramon
Visedo Ceballos, Guillermo
Provencio, Mariano
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18736 - E18736
[37] JAK inhibitors: risk of major adverse cardiovascular events
Reactions Weekly, 2025, 2052 (1) : 8 - 8
[38] Adverse cardiovascular events in patients treated with mogamulizumab
Kwan, Jennifer M.
Henry, Mariana L.
Cook, Kirstin
Higgins, Angela
Cuomo, Jason
Foss, Francine
Baldassarre, Lauren A.
AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2021, 9
[39] Prediabetes as a risk factor for major adverse cardiovascular events
Mando, Ramy
Waheed, Muhammad
Michel, Adrian
Karabon, Patrick
Halalau, Alexandra
ANNALS OF MEDICINE, 2021, 53 (01) : 2090 - 2098
[40] Surgery in Cancer Patients: Risk Factors for Major Adverse Cardiac Events
Yong Yang
Hong-Zhi Wang
Indian Journal of Surgery, 2020, 82 : 1011 - 1015

← 1 2 3 4 5 →